Skip to main content

and
  1. Article

    Open Access

    Evaluating mismatch repair deficiency in colorectal cancer biopsy specimens

    Mismatch repair (MMR) testing on all new cases of colorectal cancer (CRC) has customarily been preferably performed on surgical specimens, as more tissue is available; however, new clinical trials for the use ...

    F. Grillo, M. Paudice, A. Gambella, S. Bozzano in Histochemistry and Cell Biology (2023)

  2. Article

    Open Access

    Correction to: Simplified Histologic Mucosal Healing Scheme (SHMHS) for inflammatory bowel disease: a nationwide multicenter study of performance and applicability

    A. Caputo, P. Parente, M. Cadei, M. Fassan, A. Rispo in Techniques in Coloproctology (2023)

  3. Article

    Open Access

    Simplified Histologic Mucosal Healing Scheme (SHMHS) for inflammatory bowel disease: a nationwide multicenter study of performance and applicability

    Assessment of mucosal healing is important for the management of patients with inflammatory bowel disease (IBD), but endoscopy can miss microscopic disease areas that may relapse. Histological assessment is in...

    A. Caputo, P. Parente, M. Cadei, M. Fassan, A. Rispo in Techniques in Coloproctology (2022)

  4. No Access

    Article

    CROCC-mutated rhabdoid colorectal carcinoma showing in intercellular spaces lamellipodia and cellular projections revealed by electron microscopy

    Rhabdoid colorectal carcinoma (RC) is a rare lesion localized to the proximal colon of patients with a mean age at diagnosis of around 70 years. This tumor shows an aggressive behavior with an overall survival...

    Andrea Remo, M. P. Cecchini, D. Benati, P. Bernardi, E. Manfrin in Virchows Archiv (2019)

  5. No Access

    Article

    Tryptophan metabolism along the kynurenine and serotonin pathways reveals substantial differences in colon and rectal cancer

    Induction of tryptophan (TRP) catabolism is an adaptation mechanism to restrict excessive acute immune response in tissues. In the tumour microenvironment, TRP catabolism’s dysregulation plays an important rol...

    S. Crotti, E. D’Angelo, C. Bedin, M. Fassan, S. Pucciarelli, D. Nitti in Metabolomics (2017)

  6. No Access

    Article

    Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study

    The occurrence of a second primary esophageal carcinoma (EC) in long-term cancer survivors may represent a late effect of previous radio-chemotherapeutic treatment. To identify the genetic factors that could i...

    E Boldrin, E Rumiato, M Fassan, M Rugge, M Cagol, D Marino in The Pharmacogenomics Journal (2016)

  7. Article

    Open Access

    Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis

    In this study, we evaluated whether the presence of genetic alterations detected by next generation sequencing may define outcome in a prognostically-selected and histology-restricted population of resected ga...

    E. Bria, S. Pilotto, M. Simbolo, M. Fassan, G. de Manzoni in Scientific Reports (2016)

  8. Article

    Open Access

    Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer

    Impairment of the immune response and aberrant expression of microRNAs are emerging hallmarks of tumour initiation/progression, in addition to driver gene mutations and epigenetic modifications. We performed a...

    T Colangelo, G Polcaro, P Ziccardi, B Pucci, L Muccillo, M Galgani in Cell Death & Disease (2016)

  9. Article

    Open Access

    Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells

    Pancreatic ductal adenocarcinoma (PDAC) is among the most aggressive human malignancies with an overall 5-year survival rate of <5%. Despite significant advances in treatment of the disease during the past dec...

    B P Kaistha, T Honstein, V Müller, S Bielak, M Sauer in British Journal of Cancer (2014)

  10. Article

    Open Access

    Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to Sunitinib in metastatic renal cancer

    Recently, we developed an apoptotic assay for expanding the monitoring capabilities of the circulating tumour cells (CTC) test during therapy. An automated platform for computing CTCs was integrated with a mAb...

    E Rossi, M Fassan, M Aieta, F Zilio, R Celadin, M Borin in British Journal of Cancer (2012)

  11. No Access

    Article

    Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread

    ApoJ/Clusterin (CLU) is a heterodimeric protein localized in the nucleus, cytoplasm or secretory organelles and involved in cell survival and neoplastic transformation. Its function in human cancer is still hi...

    S Bettuzzi, P Davalli, S Davoli, O Chayka, F Rizzi, L Belloni, D Pellacani in Oncogene (2009)

  12. No Access

    Article

    MITOSTATIN, a putative tumor suppressor on chromosome 12q24.1, is downregulated in human bladder and breast cancer

    Allelic deletions on human chromosome 12q24 are frequently reported in a variety of malignant neoplasms, indicating the presence of a tumor suppressor gene(s) in this chromosomal region. However, no reasonable...

    A Vecchione, M Fassan, V Anesti, A Morrione, S Goldoni, G Baldassarre, D Byrne in Oncogene (2009)